A Driven and Passionate Team
We are a team dedicated to defeating degeneration. We are passionate about solving problems with rigorous science and translational medicine. We have joined together to discover and develop therapies that will change the lives of patients suffering from neurodegenerative disease.
We have assembled a team with deep scientific, clinical, business and leadership experience and expertise in biotechnology, and specifically in neurodegenerative diseases.
Denali was founded by Drs. Marc Tessier-Lavigne, Ryan Watts, Alex Schuth and founding investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines.
Board of Directors
Success is accelerated by experience, collaboration and leadership. Denali’s Board of Directors combines expertise across industry, academia, drug development and the investment community, unified by the mission to improve the lives of patients.